Life Sciences Outlook | 2017
Low vacancy and an increase in demand for life sciences real estate is giving landlords the leverage they need to command higher and higher rates from tenants.
Investor interest in elite clusters like Boston and the Bay Area hasn't shown any signs of slowing down, as construction ramps up across many supply-constrained markets.
Despite higher costs as a result, companies want to remain in these top tier clusters in order to ensure theyhave access to the best talent. And as the industry grows, the amount of jobs and commercial space willneed to grow with it.
In our report you’ll learn more about the emerging clusters with room for growth and the key industry trendswe’ll be keeping our eyes on throughout the year.
We’ve once again scored the top 15 markets based based on their life sciences employment, number of establishments and funding availability.
See how each stacks up so you can better choose your next location.
Click on each market pin for a complete breakdown of our local research data.
The cost of doing business is up, despite a relatively low industry employment growth rate over the past five years. Why? High demand for skilled workers from within a small labor pool has boosted wages, which impacts bottom lines.
To find value, companies have been outsourcing research through contract research organizations (CROs) to maximize cost efficiency and productivity.
As companies fight for the best talent, space that improves the well-being of employees is becoming a top priority.
These amenity-rich layouts put an emphasis on social spaces intended for downtime and mingling among coworkers. It's all part of a broader effort to boost talent attraction and retention.
VC funding for life sciences is still near the top of the heap, but biotech is getting even more creative when it comes to securing research dollars.
Big Bio is now taking a page out of Big Pharma's playbook by using strategic partnerships to support drug development. It allows new products to come via M&A activity rather than solely with in-house development.
Executive Managing Director, Industries
International Director | Corporate Solutions | Life Sciences
Director of Research